Company Analysis
Sign in

Capstone Holding Corp. (CAPS)

Nasdaq: CAPS · Wholesale-Lumber & Other Construction Materials · Alsip, IL · filing with the SEC since 1994
Full chart Alerts Compare
Grade3.4
◀ Past 2.1● Present 3.4▶ Future 4.3
3 est.
OverviewBusinessFinancialsGradeForecastSentimentOwnershipPeopleFilingsPatents Chart

Patents

US patents through Dec 31, 2025 · PatentsView, from the USPTO’s Open Data Portal · read Oct 27, 2026

25 patents granted to the name below, as the owner printed on each patent when it was granted. A later sale, a lapse or an expiry is not read, so this is what was granted to Capstone Holding Corp.’s names, not what it holds today.

Patents granted
25
23 utility, 2 design, 1976 to Dec 31, 2025
Granted in 2025
none
in the last year the record reads
Applications published
5
since 2001, to Dec 31, 2025
Names they are printed under
1
a former name
By yearGrantedApplications published
'94'95'96'97'98'99'04'06'07'08'09'10'11
Each pair is one calendar year. Applications are published about eighteen months after filing, so the newest years read low.
Under which name1 counted
Orthologic Corp. a former name
US, as the owner printed on each patent
25 granted
5 published
Newest grantseach row opens the USPTO’s own copy
GrantedPatentTitleFieldOwner as printed
May 3, 20117,935,341Antibodies to complementary peptides of thrombin or portions thereofPharmaceuticalsOrthologic Corp.
Apr 5, 20117,919,457Thrombin peptide derivative dimersPharmaceuticalsOrthologic Corp.
Jan 25, 20117,875,588Methods of therapy using pharmaceutical composition for thrombin peptide derivativesPharmaceuticalsOrthologic Corp.
Nov 16, 20107,833,982Methods of treating dermal ulcers with thrombin derived peptidesPharmaceuticalsOrthologic Corp.
Jun 8, 20107,732,411Methods of therapy with thrombin derived peptidesPharmaceuticalsOrthologic Corp.
Nov 25, 20087,456,250Thrombin peptide derivative dimersPharmaceuticalsOrthologic Corp.
May 27, 20087,378,500Use of thrombin-derived peptides for the therapy of chronic dermal ulcersPharmaceuticalsOrthologic Corp.
Dec 4, 20077,304,035Stimulation of bone growth with thrombin peptide derivativesPharmaceuticalsOrthologic Corp.
Nov 6, 20077,291,596Pharmaceutical composition for thrombin peptide derivativesPharmaceuticalsOrthologic Corp.
May 8, 20077,214,661Methods of therapy with thrombin derived peptidesPharmaceuticalsOrthologic Corp.
Newest applications publishedan application is a clue, never a plan
PublishedApplicationTitleFieldOwner as printed
May 19, 20112011/0117075THROMBIN DERIVED PEPTIDES FOR SMOOTH MUSCLE RELAXATIONPharmaceuticalsOrthologic Corp.
May 12, 20112011/0110920METHOD OF TREATING PERIPHERAL ARTERIAL DISEASEPharmaceuticalsOrthologic Corp.
May 5, 20112011/0105400METHODS FOR TREATING ACUTE MYOCARDIAL INFARCTIONPharmaceuticalsOrthologic Corp.
May 14, 20092009/0124550Thrombin peptide derivative dimersPharmaceuticalsOrthologic Corp. · patent 7,919,457 granted from it
Apr 29, 20042004/0082885Combination pro/supination and flexion therapeutic mobilization deviceMedical technologyOrthologic Corp. · patent 7,101,347 granted from it

A patent is counted where the owner printed on it when it was granted carries the company’s own name, a former name, the name of a subsidiary its annual report lists, or its own name with a patent-holding phrase (Technology Licensing, Intellectual Property and the like), once the legal form, case and punctuation are set aside, and prints a country that name counts in. PatentsView’s data are published under the Creative Commons Attribution 4.0 licence. Source: PatentsView's granted patents and pre-grant publications, disambiguated, from the USPTO's Open Data Portal, through Dec 31, 2025, read Oct 27, 2026.

SI Assistanton CAPS · research, not advice